We/PRP seek/VBP to/TO address/VB the/DT lack/NN of/IN labeled/VBN data/NNS (/-LRB- and/CC high/JJ cost/NN of/IN annotation/NN )/-RRB- for/IN textual/JJ entailment/NN in/IN some/DT domains/NNS ./.
To/IN that/DT end/NN ,/, we/PRP first/RB create/VB (/-LRB- for/IN experimental/JJ purposes/NNS )/-RRB- an/DT entailment/NN dataset/NN for/IN the/DT clinical/JJ domain/NN ,/, and/CC a/DT highly/RB competitive/JJ supervised/JJ entailment/NN system/NN ,/, ENT/NNP ,/, that/DT is/VBZ effective/JJ (/-LRB- out/IN of/IN the/DT box/NN )/-RRB- on/IN two/CD domains/NNS ./.
We/PRP then/RB explore/VB self/NN -/HYPH training/NN and/CC active/JJ learning/NN strategies/NNS to/TO address/VB the/DT lack/NN of/IN labeled/VBN data/NNS ./.
With/IN self/NN -/HYPH training/NN ,/, we/PRP successfully/RB exploit/VBP unlabeled/JJ data/NNS to/TO improve/VB over/IN ENT/NNP by/IN 15/CD percent/NN F/NN -/HYPH score/NN on/IN the/DT newswire/NN domain/NN ,/, and/CC 13/CD percent/NN F/NN -/HYPH score/NN on/IN clinical/JJ data/NNS ./.
On/IN the/DT other/JJ hand/NN ,/, our/PRP$ active/JJ learning/NN experiments/NNS demonstrate/VBP that/IN we/PRP can/MD match/VB (/-LRB- and/CC even/RB beat/VB )/-RRB- ENT/NN using/VBG only/RB 6.6/CD percent/NN of/IN the/DT training/NN data/NNS in/IN the/DT clinical/JJ domain/NN ,/, and/CC only/RB 5.8/CD percent/NN of/IN the/DT training/NN data/NNS in/IN the/DT newswire/NN domain/NN ./.
